Hemogenyx Pharmaceuticals PLC Announces Presentation at CBD S&T Conference

LONDON, UNITED KINGDOM / ACCESSWIRE / August 28, 2024 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the clinical-stage biopharmaceutical group developing treatments for cancers and viral diseases, is pleased to announce its participation in the 2024 …
Jetzt den vollständigen Artikel lesen